Literature DB >> 23305919

Mitochondrial dysfunction contributes to the cytotoxicity of some 3,5-bis(benzylidene)-4-piperidone derivatives in colon HCT-116 cells.

Muath Helal1, Umashankar Das, Brian Bandy, Azharul Islam, Adil J Nazarali, Jonathan R Dimmock.   

Abstract

The objectives of this study are to investigate the possible ways by which the curcumin analogs 2a and 2b exert their antiproliferative properties. The analogs 2a and 2b have submicromolar IC(50) values towards human HCT-116 colon cancer cells but are far less toxic to human non-malignant CRL-1790 colon cells. Both compounds affected a number of mitochondrial functions in HCT-116 cells namely increasing the intracellular concentrations of reactive oxygen species, inhibiting oxygen consumption and decreasing the mitochondrial membrane potential. These molecules also produced swelling of isolated rat liver mitochondria, supporting a mitochondrial mechanism of cytotoxicity. Both compounds reacted with glutathione in the presence of glutathione S-transferase π and hence they may be classified as thiol alkylators.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23305919     DOI: 10.1016/j.bmcl.2012.12.016

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  Characterization of the host-guest complex of a curcumin analog with β-cyclodextrin and β-cyclodextrin-gemini surfactant and evaluation of its anticancer activity.

Authors:  Masoomeh Poorghorban; Umashankar Das; Osama Alaidi; Jackson M Chitanda; Deborah Michel; Jonathan Dimmock; Ronald Verrall; Pawel Grochulski; Ildiko Badea
Journal:  Int J Nanomedicine       Date:  2015-01-12

2.  Design, Syntheses, and Bioevaluations of Some Novel N2-Acryloylbenzohydrazides as Chemostimulants and Cytotoxic Agents.

Authors:  Kinjal Lakhani; Edgar A Borrego; Karla G Cano; Jonathan R Dimmock; Renato J Aguilera; Swagatika Das; Praveen K Roayapalley; Rajendra K Sharma; Umashankar Das
Journal:  Medicines (Basel)       Date:  2021-06-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.